Fundación Nacional de Dermatología
Welcome,         Profile    Billing    Logout  
 5 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Llanos-Cuentas, Alejandro
NCT04515186: Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World

Active, not recruiting
3
184
RoW
Meglumine Antimoniate, Glucantime®, Miltefosine, Impavido®, Thermotherapy machine, ThermoMed™
Drugs for Neglected Diseases
Cutaneous Leishmaniases
11/23
02/24
FLAME, NCT05690841: FocaL Mass Drug Administration for Vivax Malaria Elimination

Recruiting
3
7530
RoW
Focal Mass Drug Administration (fMDA)
University of California, San Francisco, Universidad Peruana Cayetano Heredia- subcontractor to UCSF as local Sponsor, PATH, Stanford University, Eijkman Oxford Clinical Research Unit, Indonesia, Menzies School of Health Research, National Institute of Allergy and Infectious Diseases (NIAID)
Malaria, Vivax, Malaria
05/27
05/27
HECT, NCT01277796: Pilot Study Using a Heat Pack to Treat Cutaneous Leishmaniasis

Available
N/A
US, RoW
Heat pack conduction-heat therapy
Universidad Peruana Cayetano Heredia, Tulane University School of Medicine
Cutaneous Leishmaniasis
 
 
soto, jaime
NCT04799236: Treatment of Mucosal Bolivian Leishmaniasis

Recruiting
3
120
RoW
Group 1: Miltefosine, Group 2: Pentavalent Antimony, Group 3: Liposomal amphotericin B
Fundacion Nacional de Dermatologia, Hospital Dermatologico de Jorochito, Centro Nacional de Enfermedades Tropicales CENETROP, ABF Foundation for Medical Research
Mucosal Leishmaniasis
04/24
11/24
NCT04515186: Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World

Active, not recruiting
3
184
RoW
Meglumine Antimoniate, Glucantime®, Miltefosine, Impavido®, Thermotherapy machine, ThermoMed™
Drugs for Neglected Diseases
Cutaneous Leishmaniases
11/23
02/24
Machado, Paulo RL
NCT04515186: Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World

Active, not recruiting
3
184
RoW
Meglumine Antimoniate, Glucantime®, Miltefosine, Impavido®, Thermotherapy machine, ThermoMed™
Drugs for Neglected Diseases
Cutaneous Leishmaniases
11/23
02/24
NCT06449040: Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the Elderly

Completed
1/2
28
RoW
Liposomal amphotericin B (AmBisome®)
Hospital Universitário Professor Edgard Santos, Instituto Gonçalo Muniz FIOCRUZ BA
Cutaneous Leishmaniasis, American
09/21
09/23
Hueb, Marcia
NCT04515186: Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World

Active, not recruiting
3
184
RoW
Meglumine Antimoniate, Glucantime®, Miltefosine, Impavido®, Thermotherapy machine, ThermoMed™
Drugs for Neglected Diseases
Cutaneous Leishmaniases
11/23
02/24
Pascale, Juan Miguel
NCT04515186: Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World

Active, not recruiting
3
184
RoW
Meglumine Antimoniate, Glucantime®, Miltefosine, Impavido®, Thermotherapy machine, ThermoMed™
Drugs for Neglected Diseases
Cutaneous Leishmaniases
11/23
02/24
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Llanos-Cuentas, Alejandro
NCT04515186: Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World

Active, not recruiting
3
184
RoW
Meglumine Antimoniate, Glucantime®, Miltefosine, Impavido®, Thermotherapy machine, ThermoMed™
Drugs for Neglected Diseases
Cutaneous Leishmaniases
11/23
02/24
FLAME, NCT05690841: FocaL Mass Drug Administration for Vivax Malaria Elimination

Recruiting
3
7530
RoW
Focal Mass Drug Administration (fMDA)
University of California, San Francisco, Universidad Peruana Cayetano Heredia- subcontractor to UCSF as local Sponsor, PATH, Stanford University, Eijkman Oxford Clinical Research Unit, Indonesia, Menzies School of Health Research, National Institute of Allergy and Infectious Diseases (NIAID)
Malaria, Vivax, Malaria
05/27
05/27
HECT, NCT01277796: Pilot Study Using a Heat Pack to Treat Cutaneous Leishmaniasis

Available
N/A
US, RoW
Heat pack conduction-heat therapy
Universidad Peruana Cayetano Heredia, Tulane University School of Medicine
Cutaneous Leishmaniasis
 
 
soto, jaime
NCT04799236: Treatment of Mucosal Bolivian Leishmaniasis

Recruiting
3
120
RoW
Group 1: Miltefosine, Group 2: Pentavalent Antimony, Group 3: Liposomal amphotericin B
Fundacion Nacional de Dermatologia, Hospital Dermatologico de Jorochito, Centro Nacional de Enfermedades Tropicales CENETROP, ABF Foundation for Medical Research
Mucosal Leishmaniasis
04/24
11/24
NCT04515186: Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World

Active, not recruiting
3
184
RoW
Meglumine Antimoniate, Glucantime®, Miltefosine, Impavido®, Thermotherapy machine, ThermoMed™
Drugs for Neglected Diseases
Cutaneous Leishmaniases
11/23
02/24
Machado, Paulo RL
NCT04515186: Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World

Active, not recruiting
3
184
RoW
Meglumine Antimoniate, Glucantime®, Miltefosine, Impavido®, Thermotherapy machine, ThermoMed™
Drugs for Neglected Diseases
Cutaneous Leishmaniases
11/23
02/24
NCT06449040: Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the Elderly

Completed
1/2
28
RoW
Liposomal amphotericin B (AmBisome®)
Hospital Universitário Professor Edgard Santos, Instituto Gonçalo Muniz FIOCRUZ BA
Cutaneous Leishmaniasis, American
09/21
09/23
Hueb, Marcia
NCT04515186: Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World

Active, not recruiting
3
184
RoW
Meglumine Antimoniate, Glucantime®, Miltefosine, Impavido®, Thermotherapy machine, ThermoMed™
Drugs for Neglected Diseases
Cutaneous Leishmaniases
11/23
02/24
Pascale, Juan Miguel
NCT04515186: Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World

Active, not recruiting
3
184
RoW
Meglumine Antimoniate, Glucantime®, Miltefosine, Impavido®, Thermotherapy machine, ThermoMed™
Drugs for Neglected Diseases
Cutaneous Leishmaniases
11/23
02/24

Download Options